Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc SQIDF


Primary Symbol: V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by FactFinder1994on Apr 04, 2023 9:29am
125 Views
Post# 35378189

SQI Partnered with Best of the Best.....

SQI Partnered with Best of the Best.....

(UHN & LUNG BIOENGINEERING)

The map is needed because lung transplant operations are a race against time - and doctors need to make rapid decisions based on the best available information.

"When we put lungs on the EVLP platform, we are able to generate a tremendous amount of information on the ability of the lung to properly function and, importantly, this data represents lung function in isolation - free from confounding signals that arise from the rest of the body," Sage says. 

"Our goal is to develop novel testing modalities that can provide detailed information to the surgeon to make enhanced decisions about the organ."

The rapid diagnostics tool - called the Toronto Lung Score - quickly details the injury status of the organ, inflammation and likelihood of ideal post-transplant outcomes, among other information, based on a small sample of solution that travels through the lungs on the EVLP system. It’s being developed in partnership with SQI Diagnostics , a Toronto-based diagnostics development company. 

At present, the tool provides results in under 40 minutes, but the team is working to trim the response time to less than 15. 

Working across disciplines, University of Toronto and UHN ...myScience Canadahttps://www.myscience.ca › news › wire › working_ac...
 

<< Previous
Bullboard Posts
Next >>